Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy Media ReleaseCarolyn MillerApril 7, 2017Prota Therapeutics, Paul Kelly
Find-Me Technologies Strengthens the Board in Readiness for Rapid Growth Media Release, AnnouncementCarolyn MillerFebruary 20, 2017Find-Me Technologies, Anne-Marie Birkill
OneVentures awarded Biomedical Translation $170M Funding Announcement, Media ReleaseCarolyn MillerDecember 14, 2016OneVentures, Paul Kelly
Clinical Genomics Strenghtens it's Leadership Team with Multiple Key Appointments Media ReleaseCarolyn MillerOctober 19, 2016Clinical Genomics, Paul Kelly
Data published in Cancer Medicine Demostrate Clinical Genomics' Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test Media ReleaseCarolyn MillerOctober 19, 2016Clinical Genomics, Paul Kelly
OneVentures appoints Dr Graeme Wald to life sciences investment team Media ReleaseCarolyn MillerAugust 31, 2016OneVentures, Paul Kelly, Anne-Marie Birkill, Michelle Deaker
DoseMe partners with Charm Health to improve management of high risk oncology medicines and deliver “precision medicine” to Australian cancer patients Media ReleaseCarolyn MillerJuly 18, 2016Anne-Marie Birkill, Charm Health
Icon Group signs up Charm Health to support cancer care Media ReleaseCarolyn MillerApril 19, 2016Anne-Marie Birkill, Charm Health
Thinking beyond the ideas boom: What Australia really needs is later stage capital and experience Media ReleaseCarolyn MillerMarch 10, 2016Michelle Deaker, OneVentures
OneVentures’ Innovation and Growth Fund II hits $100 million in FUM Media ReleaseCarolyn MillerDecember 17, 2015Michelle Deaker, Anne-Marie Birkill, Paul Kelly, OneVentures
OneVentures commits $3M to launch Australian wearable technology innovation for global dementia market Media ReleaseCarolyn MillerDecember 15, 2015Anne-Marie Birkill, OneVentures
Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S. Media ReleaseCarolyn MillerMarch 26, 2015Hatchtech
Hatchtech announces successful results from Phase 2 ovicidal study Media ReleaseCarolyn MillerOctober 21, 2014Hatchtech, Paul Kelly
Vaxxas Selected as World Economic Forum Technology Pioneer 2015 Awards, Media ReleaseCarolyn MillerAugust 26, 2014Vaxxas, Paul Kelly
charmhealth names Gary Lakin as new CEO Media ReleaseCarolyn MillerMarch 24, 2014Charm Health, Anne-Marie Birkill
Hatchtech receives FDA special protocol agreement of DeOvo™ phase III studies and strengthens patent portfolio Media ReleaseCarolyn MillerDecember 12, 2013Paul Kelly
Hatchtech completes $12.5M capital raise, secures funds for phase III trial and NDA submissions, and announces board changes Media ReleaseCarolyn MillerOctober 31, 2013Hatchtech, Paul Kelly
charmhealth appoints Health-IT Expert to the Board Media ReleaseCarolyn MillerSeptember 25, 2013Charm Health, Anne-Marie Birkill
NICTA’s ‘Incoming’ mobile video start-up company switches on with $1.1M in seed financing Media ReleaseCarolyn MillerMay 2, 2013Incoming Media, Michelle Deaker
